Publication | Closed Access

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)

Hematological MalignancyTumor BiologyRadiation OncologyAcute Myeloblastic LeukemiaHematologyMyeloid NeoplasiaAdult T-cell Leukemia-lymphomaSystems BiologyMedicineCell BiologyCell SignalingClinical OutcomeCancer ResearchHealth Sciences